Earlier this summer, we brought together all of our US sales teams for our first One Team Field Meeting in Orlando, FL, where we celebrated our successes, aligned on priorities for the coming year, and recognized our peak performers, all in the service of delivering therapies with the potential for improving lives. #SumitomoLife
Sumitomo Pharma America, Inc.
Pharmaceutical Manufacturing
Marlborough, Massachusetts 73,106 followers
We are united in our mission to deliver patient-needed therapies sooner.
About us
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and CNS. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company. Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Marlborough, Massachusetts
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
84 Waterford Drive
Marlborough, Massachusetts 01752, US
Employees at Sumitomo Pharma America, Inc.
Updates
-
Sumitomo Pharma America is happy to share that the European Medicines Agency has granted Orphan Drug Designation to our investigational therapy for relapsed or refractory #myelofibrosis. Read more: https://ow.ly/cKZh50WxtMP
-
-
Sumitomo Pharma America employees are united in their mission to deliver life-changing therapies for patients around the world. If you or someone in your network has a passion for collaboration, innovation and delivering life-changing treatments on behalf of patients, explore our open positions: https://lnkd.in/giBtVeSH #SumitomoLife
-
-
About 70% of women in the United States will have uterine fibroids by the time they reach menopause. In recognition for #FibroidAwarenessMonth this July, SMPA reaffirms its ongoing commitment to empowering individuals through education and resources about uterine fibroids. Learn how you can take charge of your health and support awareness efforts in your community: https://lnkd.in/dF24kzpt
-
-
Our team is proud to spread awareness of rare diseases like congenital athymia through Charlie’s story now airing on YouTube medical stories: https://ow.ly/oyG750Wpl3A
-
-
This #FibroidAwarenessMonth, we shine a light on the 26 million women between the ages of 15 and 50 years in the US estimated to be affected by uterine fibroids. To learn more about common symptoms, visit: https://lnkd.in/dF24kzpt
-
-
We are celebrating our two-year anniversary as Sumitomo Pharma America. We’re proud of our growth, building upon a deep heritage of the 100-year history of Sumitomo Group’s work supporting the health and wellbeing of patients. Thank you to our incredible employees and partners whose passion and dedication continues to drive our mission forward and shape our future. #Anniversary #SumitomoLife
-
-
Our own Brian Caselli, MSc, Senior Director, Regulatory Affairs, and Reyna Bishop, Associate Director, Clinical Operations, presented at the Clinical Trials in Oncology Event Series Annual East Coast conference earlier this week. Brian and Reyna shared invaluable insights on strengthening #Regulatory and #ClinicalOperations collaboration to improve processes and drive global success in #Oncology trials for patients who need it most.
-
-
Today, SMPA celebrates #IndependenceDay. Wishing everyone a joyful and safe holiday with family and friends. Follow us here on LinkedIn for more. #Sumitomolife
-
-
We are pleased to announce that former quarterback Rodney Peete has joined our partnership to encourage people with overactive bladder to speak up and seek treatment. You can read more here: https://ow.ly/QGtY50WinNb
-